Mostrar el registro sencillo del ítem

dc.contributor.authorGuirado, M.
dc.contributor.authorFernández Martín, E.
dc.contributor.authorFernández Villar, José Alberto 
dc.contributor.authorNavarro Martín, A.
dc.contributor.authorSánchez-Hernández, A.
dc.date.accessioned2025-05-14T17:07:16Z
dc.date.available2025-05-14T17:07:16Z
dc.date.issued2022
dc.identifier.issn1699-3055
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20016
dc.description.abstract[EN] Introduction: Due to the importance of lung cancer early treatment because of its severity and extent worldwide a systematic literature review was conducted about the impact of delays in waiting times on the disease prognosis. Materials and Methods: We conducted a systematic search of observational studies (2010-2020) including adult patients diagnosed with lung cancer and reporting healthcare timelines and their clinical consequences. Results: We included 38 articles containing data on waiting times and prognosis; only 31 articles linked this forecast to a specific waiting time. We identified 41 healthcare time intervals and found medians of 6-121 days from diagnosis to treatment and 4-19.5 days from primary care to specialist visit: 37.5% of the intervals indicated better prognosis with longer waiting times. Conclusions: All articles emphasized that waiting times must be reduced to achieve good management and prognosis of lung cancer. Further prospective studies are needed on the relationship between waiting times and prognosis of lung cancer.
dc.language.isoenes
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleClinical impact of delays in the management of lung cancer patients in the last decade: systematic review
dc.typeJournal Articlees
dcterms.bibliographicCitationGuirado M, Fernández Martín E, Fernández Villar A, Navarro Martín A, Sánchez-Hernández A. Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review. Clinical and Translational Oncology. 2022;24(8):1549-68.
dc.authorsophosGuirado, A. M.;Fernández Martín, E.;Fernández Villar, A.;Navarro Martín, A.;Sánchez, Hernández
dc.identifier.doi10.1007/S12094-022-02796-W
dc.identifier.sophos623f9349c8882379aff2765a
dc.issue.number8
dc.journal.titleClinical and Translational Oncology
dc.page.initial1549
dc.page.final1568
dc.relation.publisherversionhttps://link.springer.com/content/pdf/10.1007%2Fs12094-022-02796-w.pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Vigoes
dc.subject.keywordCHUVIes
dc.subject.keywordIISGSes
dc.volume.number24


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional